Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Group A streptococci in the 1990s.

A Efstratiou1

  • 1WHO Collaborating Centre for Diphtheria and Streptococcal Infections, PHLS Respiratory and Systemic Infection Laboratory, Central Public Health Laboratory, London, UK. aefstratiou@phls.nhs.uk

The Journal of Antimicrobial Chemotherapy
|April 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seroprevalence of Toxoplasma gondii infection in sheep from northern China.

Tropical biomedicine·2021
Same author

First evidence of Mycoplasma haemocanis in China.

Tropical biomedicine·2021
Same author

Molecular detection and genotyping of Anaplasma spp. and Theileria spp. infections in sheep and cattle from the northeast region of China.

Tropical biomedicine·2021
Same author

A patient with respiratory toxigenic diphtheria in Greece after more than 30 years.

Epidemiology and infection·2020
Same author

Toxigenic Corynebacterium ulcerans associated with upper respiratory infections in cats and dogs.

The Journal of small animal practice·2020
Same author

The epidemiology of severe Streptococcus pyogenes associated disease in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Group A Streptococcus infections are increasing globally, with more severe invasive cases and re-emerging acute rheumatic fever. Virulent strains and toxins are key factors driving this trend.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Global epidemiology of Group A Streptococcus (Streptococcus pyogenes) infections shows a marked increase in invasive cases over the past decade.
  • Severe infections, including streptococcal toxic shock syndrome with multi-organ failure, are increasingly reported.
  • Re-emergence of acute rheumatic fever in developed countries highlights ongoing public health concerns.

Purpose of the Study:

  • To analyze the changing epidemiology of Group A streptococcal infections.
  • To investigate the role of specific bacterial strains and virulence factors in disease.
  • To underscore the need for enhanced understanding of pathogenesis, treatment, and prevention.

Main Methods:

  • Review of epidemiological data and surveillance studies on Streptococcus pyogenes.

Related Experiment Videos

  • Analysis of emerging trends in invasive infections and sequelae like acute rheumatic fever.
  • Examination of the contribution of bacterial virulence factors, including M protein and pyrogenic exotoxins.

    • Main Results:

    • Significant global rise in invasive Group A Streptococcus infections, including severe forms like streptococcal toxic shock syndrome.
    • Resurgence of acute rheumatic fever, posing a continued threat in developed nations.
    • Identification of specific virulent strains, such as M1 serotype, and key virulence factors (e.g., M protein, toxins) associated with increased disease severity.

    Conclusions:

    • The epidemiology of Group A Streptococcus infections has shifted, characterized by increased virulence and invasive potential.
    • Bacterial type distribution and specific virulence factors are crucial for understanding disease patterns.
    • Further research into the epidemiology, pathogenesis, treatment, and prevention of these infections is urgently needed.